VRTX Stock Price Forecast. Should You Buy VRTX?
Stock Details
VRTX 540
Oppenheimer Reiterates Outperform Rating on Vertex (VRTX)
Hartaj Singh·Tue Nov 05 2024
Oppenheimer
VRTX 451
Vertex (VRTX) PT Raised to $451 at RBC Capital
Brian Abrahams·Tue Nov 05 2024
RBC Capital
VRTX 361
Canaccord Genuity Reiterates Sell Rating on Vertex (VRTX)
Whitney Ijem·Tue Oct 22 2024
Canaccord Genuity
VRTX 566
BMO Capital Reiterates Outperform Rating on Vertex (VRTX)
Evan David Seigerman·Mon Oct 21 2024
BMO Capital
VRTX 598
Goldman Sachs Reiterates Buy Rating on Vertex (VRTX)
Salveen Richter·Mon Oct 21 2024
Goldman Sachs
VRTX 541
Vertex Pharmaceuticals price target lowered to $541 from $550 at BofA
Geoff Meacham·Mon Oct 14 2024
Bank of America Securities
VRTX 437
Vertex Pharmaceuticals price target raised to $437 from $425 at RBC Capital
Brian Abrahams·Wed Oct 09 2024
RBC Capital
VRTX 550
Vertex Pharmaceuticals price target raised to $550 from $508 at Truist
Joon Lee·Mon Aug 05 2024
Truist Financial
VRTX 550
Vertex (VRTX) PT Raised to $550 at Oppenheimer
Hartaj Singh·Mon Aug 05 2024
Oppenheimer
VRTX 576
Vertex (VRTX) PT Raised to $576 at Wolfe Research
Andy Chen·Mon Aug 05 2024
Wolfe Research
VRTX 600
Vertex Pharmaceuticals price target raised to $600 from $500 at H.C. Wainwright
Andrew Fein·Fri Aug 02 2024
H.C. Wainwright
VRTX 550
Vertex Pharmaceuticals price target raised to $550 from $465 at Argus
Jasper Hellweg·Mon Jun 17 2024
Argus Research
VRTX 421
Vertex (VRTX) PT Lowered to $421 at RBC Capital
Brian Abrahams·Tue Jun 11 2024
RBC Capital
VRTX 500
Vertex (VRTX) PT Raised to $500 at BMO Capital
Evan David Seigerman·Fri May 31 2024
BMO Capital
VRTX 456
Vertex (VRTX) PT Raised to $456 at Piper Sandler
Christopher Raymond·Tue May 07 2024
Raymond James
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow